Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1962 4
1963 1
1964 4
1966 2
1968 5
1969 4
1970 2
1971 7
1972 1
1973 5
1974 4
1975 7
1976 12
1977 9
1978 11
1979 14
1980 15
1981 7
1982 20
1983 26
1984 20
1985 17
1986 27
1987 24
1988 29
1989 29
1990 29
1991 25
1992 40
1993 44
1994 40
1995 55
1996 61
1997 36
1998 69
1999 66
2000 79
2001 47
2002 64
2003 59
2004 52
2005 47
2006 59
2007 71
2008 71
2009 62
2010 75
2011 74
2012 73
2013 83
2014 68
2015 50
2016 63
2017 65
2018 67
2019 64
2020 64
2021 69
2022 82
2023 69
2024 78
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,240 results

Results by year

Filters applied: . Clear all
Page 1
Berberine is an insulin secretagogue targeting the KCNH6 potassium channel.
Zhao MM, Lu J, Li S, Wang H, Cao X, Li Q, Shi TT, Matsunaga K, Chen C, Huang H, Izumi T, Yang JK. Zhao MM, et al. Among authors: izumi t. Nat Commun. 2021 Sep 23;12(1):5616. doi: 10.1038/s41467-021-25952-2. Nat Commun. 2021. PMID: 34556670 Free PMC article. Clinical Trial.
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T. Shimada K, et al. Among authors: izumi t. Lancet Oncol. 2020 Apr;21(4):593-602. doi: 10.1016/S1470-2045(20)30059-0. Epub 2020 Mar 11. Lancet Oncol. 2020. PMID: 32171071 Clinical Trial.
Editorial: "The Host-Microbiome Interplay in Colorectal Cancer".
Campillo-Gimenez L, Yang Y, De Los Reyes-Gavilan CG, Izumi T. Campillo-Gimenez L, et al. Among authors: izumi t. Front Cell Infect Microbiol. 2022 Jun 8;12:906719. doi: 10.3389/fcimb.2022.906719. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35755837 Free PMC article. No abstract available.
Lung function decline in sarcoidosis.
Tanizawa K, Handa T, Nagai S, Ikezoe K, Kubo T, Yokomatsu T, Ueda S, Fushimi Y, Ogino S, Watanabe K, Nakatsuka Y, Hirai T, Izumi T. Tanizawa K, et al. Among authors: izumi t. Respir Investig. 2022 Jul;60(4):551-561. doi: 10.1016/j.resinv.2022.02.009. Epub 2022 Apr 7. Respir Investig. 2022. PMID: 35400618
Ezetimibe and reactive oxygen species.
Yamaoka-Tojo M, Tojo T, Takahira N, Masuda T, Izumi T. Yamaoka-Tojo M, et al. Among authors: izumi t. Curr Vasc Pharmacol. 2011 Jan;9(1):109-20. doi: 10.2174/157016111793744652. Curr Vasc Pharmacol. 2011. PMID: 21044015 Review.
Atypical Incomplete Detachment Following PulseRider Deployment.
Goto S, Izumi T, Nishihori M, Araki Y, Yokoyama K, Uda K, Saito R. Goto S, et al. Among authors: izumi t. J Neuroendovasc Ther. 2022;16(8):409-412. doi: 10.5797/jnet.cr.2021-0095. Epub 2021 Dec 24. J Neuroendovasc Ther. 2022. PMID: 37502632 Free PMC article.
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis.
Suda G, Baba M, Yamamoto Y, Sho T, Ogawa K, Kimura M, Hosoda S, Yoshida S, Kubo A, Fu Q, Yang Z, Tokuchi Y, Kitagataya T, Maehara O, Ohnishi S, Yamada R, Ohara M, Kawagishi N, Natsuizaka M, Nakai M, Morikawa K, Furuya K, Suzuki K, Izumi T, Meguro T, Terashita K, Ito J, Kobayashi T, Tsunematsu I, Sakamoto N. Suda G, et al. Among authors: izumi t. J Med Virol. 2023 Feb;95(2):e28452. doi: 10.1002/jmv.28452. J Med Virol. 2023. PMID: 36597900
PPARα activation partially drives NAFLD development in liver-specific Hnf4a-null mice.
Kasano-Camones CI, Takizawa M, Ohshima N, Saito C, Iwasaki W, Nakagawa Y, Fujitani Y, Yoshida R, Saito Y, Izumi T, Terawaki SI, Sakaguchi M, Gonzalez FJ, Inoue Y. Kasano-Camones CI, et al. Among authors: izumi t. J Biochem. 2023 Apr 26;173(5):393-411. doi: 10.1093/jb/mvad005. J Biochem. 2023. PMID: 36779417 Free PMC article.
2,240 results